Kiora Pharmaceuticals, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Kiora Pharmaceuticals, Inc. now
Current reporting with the operating signal separated from the noise.
Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Announces Private Placement for Up to $24 Million Led by Perceptive Advisors
The story matters when it changes Kiora Pharmaceuticals, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model
The story matters when it changes Kiora Pharmaceuticals, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: official volume, pricing, inventory and segment margin.Latest KPRX filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Kiora Pharmaceuticals, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →